The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...

T-cell therapy is a type of cancer immunotherapy where patients' T-cells are collected and genetically modified to produce ...

According to Governor Glenn Youngkin's executive order, it is up to individual school boards to be clear on their protocol.

All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...

Education Minister Krista Lynn Howell says it is everyone’s responsibility to ensure that government’s new cell phone policy ...

The new policy, to be implemented when students head back to class following the holiday break on January 6th, will allow ...

(WFXR) – Lynchburg City Schools have announced their ‘Off & Away All Day’ cell phone policy. When students return from their ...

This pair of posters presented at the 66th American Society of Hematology Annual Meeting & Exposition provides updates on ...

In this interview, Technology Networks spoke with Dr. Laura Lyon, product manager of cell culture technologies at Sartorius ...

For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an ...

Real-world study compares the efficacy and safety of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel), ...